MED-PHARMA
ActiveSummary
MED-PHARMA has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €743,290 and a net result of €27,863. Equity is growing by ~4.5% per year across the filed fiscal years. Its solvency ranks better than 84% of 26043 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability67▼-6
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55,000 at 30 days acceptable
Liquidity tight (current ratio 1.16 against 1.04 in 2023; short-term debt: 24.4% of total assets), and 24.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
75.5%
Return on assets
2.8%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
97 d late
2022
85 d late
2021
90 d late
2020
89 d late
2019
122 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 91 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€743,290▲ 3.9%
2023 · €715,426
Total assets
€983,914▲ 2.9%
2023 · €956,279
Net result
€27,863▼ 9.7%
2023 · €30,851
Working capital
€37,724▲ 347%
2023 · €8,431
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€50,502▲ 12.1%€44,853▼ 11.2%€48,450▲ 8.0%€43,359▼ 10.5%€28,832▼ 33.5%
Net result€32,776above the sector's middle half▲ 61.9%€30,574above the sector's middle half▼ 6.7%€29,574above the sector's middle half▼ 3.3%€30,851above the sector's middle half▲ 4.3%€27,863above the sector's middle half▼ 9.7%
Equity€624,427above the sector's middle half▲ 5.5%€655,001above the sector's middle half▲ 4.9%€684,575above the sector's middle half▲ 4.5%€715,426above the sector's middle half▲ 4.5%€743,290above the sector's middle half▲ 3.9%
Total assets€861,963above the sector's middle half▲ 2.1%€888,689above the sector's middle half▲ 3.1%€907,425above the sector's middle half▲ 2.1%€956,279above the sector's middle half▲ 5.4%€983,914above the sector's middle half▲ 2.9%
Debt€237,536▼ 5.9%€233,688▼ 1.6%€222,850▼ 4.6%€240,853▲ 8.1%€240,624▼ 0.1%
Working capital-€64,474below the sector's middle half▲ 16.2%-€53,338below the sector's middle half▲ 17.3%-€22,987below the sector's middle half▲ 56.9%€8,431within the sector's middle half€37,724within the sector's middle half▲ 347%
Solvency72.4%above the sector's middle half▲ 2.3pp73.7%above the sector's middle half▲ 1.3pp75.4%above the sector's middle half▲ 1.7pp74.8%above the sector's middle half▼ 0.6pp75.5%above the sector's middle half▲ 0.7pp
Current ratio0.70below the sector's middle half▲ 0.070.77below the sector's middle half▲ 0.070.90within the sector's middle half▲ 0.131.04within the sector's middle half▲ 0.141.16within the sector's middle half▲ 0.12
Return on assets (ROA)3.8%within the sector's middle half▲ 1.4pp3.4%within the sector's middle half▼ 0.4pp3.3%within the sector's middle half▼ 0.2pp3.2%within the sector's middle half=2.8%within the sector's middle half▼ 0.4pp
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 34% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €983,914
Fixed assets
€706,533 ▼ 0.1%
Current assets
€277,381 ▲ 11.3%
Equity and liabilities €983,914
Equity
€743,290 ▲ 3.9%
Debt
€240,624 ▼ 0.1%
Debt's share of the balance-sheet total falls from 25.2% to 24.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€29,294▼
2023 · €43,926
Cash flow
€28,325▼
2023 · €31,418
Debt to equity
0.32▼
2023 · 0.34
ROE
3.7%▼
2023 · 4.3%
Interest coverage
5.38▼
2023 · 11.07
Debt ≤ 1 year
€239,657▼
2023 · €240,853
Income taxes
€9,383▼
2023 · €11,095
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €672 | €777 | €777 | €567 | €462 | ▼ 18.5% |
| Other operating charges640/8 | - | €868 | €1,177 | €1,246 | €1,216 | ▼ 2.4% |
| Gross operating margin9900 | €53,137 | €46,498 | €50,404 | €45,172 | €30,510 | ▼ 32.5% |
| Operating profit (loss)9901 | €50,502 | €44,853 | €48,450 | €43,359 | €28,832 | ▼ 33.5% |
| Financial income75/76B | - | €3,109 | €3,655 | €2,555 | €13,859 | ▲ 442% |
| Recurring financial income75 | €1,520 | €3,109 | €3,655 | €2,555 | €13,859 | ▲ 442% |
| Financial charges65/66B | - | €5,319 | €6,730 | €3,968 | €5,444 | ▲ 37.2% |
| Recurring financial charges65 | €5,843 | €5,319 | €6,730 | €3,968 | €5,444 | ▲ 37.2% |
| Profit (loss) for the period before taxes9903 | €46,179 | €42,643 | €45,375 | €41,946 | €37,246 | ▼ 11.2% |
| Income taxes67/77 | €13,403 | €12,069 | €15,801 | €11,095 | €9,383 | ▼ 15.4% |
| Profit (loss) for the period9904 | €32,776 | €30,574 | €29,574 | €30,851 | €27,863 | ▼ 9.7% |
| Profit (loss) for the period to be appropriated9905 | €32,776 | €30,574 | €29,574 | €30,851 | €27,863 | ▼ 9.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €861,963 | €888,689 | €907,425 | €956,279 | €983,914 | ▲ 2.9% |
| Fixed assets21/28 | €709,116 | €708,339 | €707,562 | €706,995 | €706,533 | ▼ 0.1% |
| Tangible fixed assets22/27 | €3,507 | €2,730 | €1,953 | €1,386 | €924 | ▼ 33.3% |
| Land and buildings22 | - | €2,310 | €1,848 | €1,386 | €924 | ▼ 33.3% |
| Furniture and vehicles24 | - | €420 | €105 | - | - | - |
| Financial fixed assets28 | €705,609 | €705,609 | €705,609 | €705,609 | €705,609 | = |
| Current assets29/58 | €152,847 | €180,350 | €199,863 | €249,284 | €277,381 | ▲ 11.3% |
| Amounts receivable after more than one year29 | - | €156,608 | €156,608 | €156,608 | €166,396 | ▲ 6.2% |
| Other amounts receivable291 | - | €156,608 | €156,608 | €156,608 | €166,396 | ▲ 6.2% |
| Amounts receivable within one year40/41 | €13,425 | €12,365 | €30,836 | €79,067 | €99,811 | ▲ 26.2% |
| Trade receivables40 | - | €11,365 | €11,305 | €12,245 | €12,185 | ▼ 0.5% |
| Other amounts receivable41 | - | €1,000 | €19,531 | €66,822 | €87,626 | ▲ 31.1% |
| Cash at bank and in hand54/58 | €840 | - | - | €91 | - | - |
| Deferred charges and accrued income490/1 | - | €11,377 | €12,419 | €13,518 | €11,173 | ▼ 17.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €861,963 | €888,689 | €907,425 | €956,279 | €983,914 | ▲ 2.9% |
| Equity10/15 | €624,427 | €655,001 | €684,575 | €715,426 | €743,290 | ▲ 3.9% |
| Contributions10/11 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Profit (loss) carried forward14 | €610,167 | €640,741 | €670,315 | €701,166 | €729,030 | ▲ 4.0% |
| Amounts payable17/49 | €237,536 | €233,688 | €222,850 | €240,853 | €240,624 | ▼ 0.1% |
| Amounts payable after more than one year17 | €20,215 | - | - | - | - | - |
| Amounts payable within one year42/48 | €217,321 | €233,688 | €222,850 | €240,853 | €239,657 | ▼ 0.5% |
| Current portion of amounts payable after more than one year42 | - | €24,776 | - | - | - | - |
| Financial debts43 | - | €23,023 | €20,431 | €11,349 | €15,941 | ▲ 40.5% |
| Credit institutions430/8 | - | €23,023 | €20,431 | €11,349 | €15,941 | ▲ 40.5% |
| Trade debts44 | €4,180 | €14,329 | €5,906 | €5,682 | €5,684 | = |
| Suppliers440/4 | - | €14,329 | €5,906 | €5,682 | €5,684 | = |
| Taxes, remuneration and social security45 | - | €9,751 | €2,228 | €14,537 | €8,846 | ▼ 39.1% |
| Taxes450/3 | - | €9,235 | €1,842 | €14,295 | €8,846 | ▼ 38.1% |
| Remuneration and social security454/9 | - | €516 | €386 | €242 | - | - |
| Other amounts payable47/48 | - | €161,809 | €194,285 | €209,285 | €209,185 | = |
| Accrued charges and deferred income492/3 | - | - | - | - | €968 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €32,776 | €30,574 | €29,574 | €30,851 | €27,863 | ▼ 9.7% |
| + Depreciation and write-downs630 | €672 | €777 | €777 | €567 | €462 | ▼ 18.5% |
| Operating cash flow (approximation) | €33,448 | €31,351 | €30,351 | €31,418 | €28,325 | ▼ 9.8% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | -€0 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
05-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 97 days late
2023
24-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 85 days late
2022
29-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 90 days late
2021
28-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 89 days late
2020
31-12
Financial
Highest result since 2018net €32,776 ▲61.9%
Operating result €50,502, net result €32,776, both a record.
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
2019
31-12
Financial
Weakest financial yearnet €20,239 ▼10.8%
Net result drops to €20,239, the lowest in the series; recovery starts the following year.
15-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 76 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 31 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2009
Ground area
113 m²
Building footprint
117 m²
Volume, LiDAR
2,164 m³
Parcel 21305C0267/00G009, Brussels · tallest building 22.0 m, ±7 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
MED-PHARMA
since 20092.182.504.948
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21305C0267/00G009 | Brussels | 113 m² | 1 · 117 m² | 22.0 m · 7 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2024 list no shareholders, and no other source names one.
Holdings 1
-
70%
According to the 2024 annual accounts of MED-PHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
APOTHEEK DE HALLEN
BE 0823.041.535
Leuven · Eq €744,100
COX
BE 0426.728.635
Hasselt · Eq €742,431
Pharmacie Savenay
BE 0443.957.716
Neupré · Eq €744,186
NOVIL'PHARMA
BE 0870.124.840
Fernelmont · Eq €744,411
APOTHEEK WILLE
BE 0431.634.360
Grimbergen · Eq €741,958
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,195 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company (pre-2019)
Founded18-09-2009
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0818652680
Also
9925:BE0818652680
Registered
17-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.